Claims for Patent: 11,806,555

Summary for Patent: 11,806,555

Title:	Methods for treating hair loss disorders
Abstract:	The invention provides for methods for treating a hair loss disorder in a subject by administering a Janus Kinase/Signal Transducers and Activators of Transcription inhibitor.
Inventor(s):	Angela M. Christiano, Raphael Clynes
Assignee:	Columbia University in the City of New York
Application Number:	US17/868,078
Patent Claims:	1. A method of treating alopecia areata in a human subject in need thereof comprising orally administering to the human subject once daily a therapeutically effective amount of LY3009104 to treat alopecia areata in the human subject. 2. The method of claim 1, wherein the alopecia areata is in patches. 3. The method of claim 1, wherein the alopecia areata is alopecia totalis. 4. The method of claim 1, wherein the alopecia areata is alopecia universalis. 5. The method of claim 1, wherein the LY3009104 is in a pharmaceutical composition further comprising a pharmaceutically acceptable carrier. 6. The method of claim 1, wherein the alopecia areata is severe alopecia areata. 7. The method of claim 6, wherein the severe alopecia areata is in patches. 8. The method of claim 6, wherein the severe alopecia areata is alopecia totalis. 9. The method of claim 6, wherein the severe alopecia areata is alopecia universalis. 10. The method of claim 6, wherein LY3009104 is in a pharmaceutical composition further comprising a pharmaceutically acceptable carrier. 11. A method of treating alopecia areata in a human subject in need thereof comprising orally administering to the human subject a therapeutically effective amount of LY3009104 to treat alopecia areata in the human subject. 12. The method of claim 11, wherein the alopecia areata is in patches. 13. The method of claim 11, wherein the alopecia areata is alopecia totalis. 14. The method of claim 11, wherein the alopecia areata is alopecia universalis. 15. The method of claim 11, wherein LY3009104 is in a pharmaceutical composition further comprising a pharmaceutically acceptable carrier. 16. The method of claim 11, wherein the alopecia areata is severe alopecia areata. 17. The method of claim 16, wherein the severe alopecia areata is in patches. 18. The method of claim 16, wherein the severe alopecia areata is alopecia totalis. 19. The method of claim 16, wherein the severe alopecia areata is alopecia universalis. 20. The method of claim 16, wherein LY3009104 is in a pharmaceutical composition further comprising a pharmaceutically acceptable carrier. 21. A method of treating severe alopecia areata in a human subject in need thereof comprising orally administering to the human subject once daily a therapeutically effective amount of LY3009104 to treat severe alopecia areata in the human subject, wherein LY3009104 is the only therapeutically effective agent being administered to the human subject for treating severe alopecia areata. 22. The method of claim 21, wherein the severe alopecia areata is in patches. 23. The method of claim 21, wherein the severe alopecia areata is alopecia totalis. 24. The method of claim 21, wherein the severe alopecia areata is alopecia universalis. 25. The method of claim 21, wherein the LY3009104 is in a pharmaceutical composition further comprising a pharmaceutically acceptable carrier.